Shares of Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) saw unusually-strong trading volume on Wednesday after Chardan Capital raised their price target on the stock from $8.45 to $9.75. Chardan Capital currently has a buy rating on the stock. Approximately 3,233,629 shares traded hands during trading, a decline of 38% from the previous session’s volume of 5,192,967 shares.The stock last traded at $7.9790 and had previously closed at $7.79.
A number of other equities research analysts have also issued reports on the stock. Maxim Group assumed coverage on shares of Hyperliquid Strategies in a report on Friday, April 24th. They set a “buy” rating and a $10.00 price objective for the company. Weiss Ratings initiated coverage on shares of Hyperliquid Strategies in a research report on Monday, March 2nd. They set a “sell (e)” rating for the company. Cantor Fitzgerald lifted their price target on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Finally, Wall Street Zen upgraded shares of Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $9.25.
View Our Latest Analysis on Hyperliquid Strategies
Institutional Inflows and Outflows
Hyperliquid Strategies Price Performance
The business has a 50 day moving average price of $5.90. The firm has a market capitalization of $1.09 billion, a P/E ratio of -1.07 and a beta of 1.44.
Hyperliquid Strategies (NASDAQ:PURR – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.01 EPS for the quarter. The business had revenue of $2.63 million during the quarter. Research analysts anticipate that Hyperliquid Strategies Inc will post -1.15 EPS for the current fiscal year.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Read More
- Five stocks we like better than Hyperliquid Strategies
- Tesla Ends Model S and X Era, Bets Everything on What’s Next
- Why AST SpaceMobile Is the Bigger Winner of the AT&T, T-Mobile, and Verizon Joint Venture
- Strategy Inc. Buys Bitcoin and Eyes a Dividend Amid Market Fear
- Vertical Aerospace: Pre-Flight Checks Point to a Breakout
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
